- Home
- UPXI vs CNSP Comparison
UPXI vs CNSP Comparison
Compare UPXI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- CNSP
- Stock Information
- Founded
- UPXI 2018
- CNSP 2017
- Country
- UPXI United States
- CNSP United States
- Employees
- UPXI N/A
- CNSP N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- UPXI Health Care
- CNSP Health Care
- Exchange
- UPXI Nasdaq
- CNSP Nasdaq
- Market Cap
- UPXI 5.1M
- CNSP 5.4M
- IPO Year
- UPXI 2021
- CNSP 2019
- Fundamental
- Price
- UPXI $4.54
- CNSP $0.11
- Analyst Decision
- UPXI Hold
- CNSP Strong Buy
- Analyst Count
- UPXI 1
- CNSP 1
- Target Price
- UPXI $25.00
- CNSP $0.50
- AVG Volume (30 Days)
- UPXI 138.9K
- CNSP 6.2M
- Earning Date
- UPXI 12-24-2024
- CNSP 11-15-2024
- Dividend Yield
- UPXI N/A
- CNSP N/A
- EPS Growth
- UPXI N/A
- CNSP N/A
- EPS
- UPXI N/A
- CNSP N/A
- Revenue
- UPXI $26,000,652.00
- CNSP N/A
- Revenue This Year
- UPXI $18.98
- CNSP N/A
- Revenue Next Year
- UPXI $8.09
- CNSP N/A
- P/E Ratio
- UPXI N/A
- CNSP N/A
- Revenue Growth
- UPXI 27.11
- CNSP N/A
- 52 Week Low
- UPXI $2.17
- CNSP $0.10
- 52 Week High
- UPXI $33.00
- CNSP $71.00
- Technical
- Relative Strength Index (RSI)
- UPXI 47.41
- CNSP 49.04
- Support Level
- UPXI $4.67
- CNSP $0.10
- Resistance Level
- UPXI $5.24
- CNSP $0.12
- Average True Range (ATR)
- UPXI 0.55
- CNSP 0.01
- MACD
- UPXI -0.03
- CNSP 0.00
- Stochastic Oscillator
- UPXI 34.39
- CNSP 56.90
About UPXI Upexi Inc.
Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.